Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2023		Dec. 31, 2022
Current Assets
Cash and cash equivalents	$ 1,805		$ 1,508
Trade receivables - third party and affiliates	1,243		1,379
Non-trade receivables, net	541		675
Inventories	2,357		2,808
Other assets	272		241
Total current assets	6,218		6,611
Investments in affiliates	1,220		1,062
Property, plant and equipment (net of accumulated depreciation - 2023: $4,080; 2022: $3,687)	5,584		5,584
Operating lease right-of-use assets	422		413
Deferred income taxes	1,677		808
Other assets	524		547
Goodwill	6,977	[1]	7,142
Intangible assets, net	3,975		4,105
Total assets	26,597		26,272
Current Liabilities
Short-term borrowings and current installments of long-term debt - third party and affiliates	1,383		1,306
Trade payables - third party and affiliates	1,510		1,518
Other liabilities	1,154		1,201
Income taxes payable	25		43
Total current liabilities	4,072		4,068
Long-term debt, net of unamortized deferred financing costs	12,301		13,373
Deferred income taxes	999		1,242
Uncertain tax positions	300		322
Benefit obligations	457		411
Operating lease liabilities	325		364
Other liabilities	591		387
Commitments and Contingencies
Shareholders' Equity
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2023 and 2022: 0 issued and outstanding)	0		0
Common stock, $0.0001 par value, 400,000,000 shares authorized (2023: 170,476,740 issued and 108,906,426 outstanding; 2022: 170,135,425 issued and 108,473,932 outstanding)	0		0
Treasury stock, at cost (2023: 61,570,314 shares; 2022: 61,661,493 shares)	(5,488)		(5,491)
Additional paid-in capital	394		372
Retained earnings	12,929		11,274
Accumulated other comprehensive income (loss), net	(744)		(518)
Total Celanese Corporation shareholders' equity	7,091		5,637
Noncontrolling interests	461		468
Total equity	7,552		6,105
Total liabilities and equity	$ 26,597		$ 26,272

[1] There were no accumulated impairment losses as of December 31, 2023.